ZURICH/BERLIN, Dec 4 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Friday:
COMPANY STATEMENTS
* Cosmo Pharmaceuticals COPN.S said it struck a licensing
deal for its methylene blue MMX product with China Medical
Systems COPN.S
* UBS UBSG.S said it intends to cancel $150 mln of
original $2 billion fixed rate notes due April 2021 UBSG.S
* Mobimo MOBN.S said it will propose Sabrina Contratto as
a new board member MOBN.S
* Achiko ACHIN.S said it agreed to partner with Udayana
University for COVID-19 testing research in Bali, Indonesia.
urn:newsml:reuters.com:*:nFWN2IJ13N
ANALYSTS' VIEWS
FLUGHAFEN ZUERICH AG FHZN.S : DEUTSCHE BANK RAISES PRICE
TARGET TO CHF 182 FROM CHF 157
ECONOMY
No major economic data scheduled.
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))